Current status and influencing factors of discharge readiness in lung cancer patients undergoing immu-notherapy combined with chemotherapy
Objective To analyze the current status of discharge readiness in lung cancer patients undergoing immuno-therapy combined with chemotherapy and identify its influencing factors.Methods A total of 262 lung cancer patients who received immunotherapy combined with chemotherapy at the Cancer Hospital,Chinese Academy of Medical Sciences and Pe-king Union Medical College from February to March 2023 were selected by convenience sampling.Questionnaires were dis-tributed to patients before discharge.The general information questionnaire,the Readiness for Hospital Discharge Scale,the Quality of Discharge Teaching Scale,and the Fear of Progression Questionnaire-Short Form were used to investigate and analyze discharge readiness and its influencing factors.Results The total score of discharge readiness was(99.27±14.92).Multiple linear regression analysis showed that gender(t=-3.038,P=0.003),age(t=-2.651,P=0.009),history of lung radiotherapy(t=1.993,P=0.047),quality of discharge teaching(t=3.540,P＜0.001),and fear of disease progression(t=-5.526,P＜0.001)were significant influencing factors for discharge readiness in lung cancer patients undergoing im-munotherapy combined with chemotherapy.Conclusion The discharge readiness score of lung cancer patients undergoing immunotherapy combined with chemotherapy is relatively high.Male patients,those younger than 60 years old,those with-out a history of lung radiotherapy,those with high discharge teaching quality scores,and those with low fear of disease pro-gression scores tend to have higher discharge readiness.
lung cancerimmunotherapy combined with chemotherapydischarge readinessinfluencing factors
国家科技期刊平台
NSTL
万方数据
